FKBP1B antibody (AA 1-108) (FITC)

Catalog No. ABIN7162829

Product Details anti-FKBP1B Antibody (FITC)

Target: FKBP1B (FK506 Binding Protein 1B, 12.6 KDa (FKBP1B))

Binding Specificity: AA 1-108

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This FKBP1B antibody is conjugated to FITC

Application: Please inquire

Cross-Reactivity: Human

Purification: >95%, Protein G purified

Immunogen: Recombinant Human Peptidyl-prolyl cis-trans isomerase FKBP1B protein (1-108aa)

Isotype: IgG

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C,-80 °C

Storage Comment: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Target Details for FKBP1B

Target: FKBP1B (FK506 Binding Protein 1B, 12.6 KDa (FKBP1B))

Alternative Name: FKBP1B (FKBP1B Products)

Synonyms: FKBP12.6 antibody, MGC68829 antibody, FKBP1B antibody, DKFZp459K1429 antibody, 12.6kDa antibody, AW494148 antibody, calstabin2 antibody, FKBP1L antibody, OTK4 antibody, PKBP1L antibody, PPIase antibody, FK506 binding protein 1B antibody, FK506 binding protein 1B L homeolog antibody, FK506 binding protein 1b antibody, FKBP1B antibody, fkbp1b.L antibody, fkbp1b antibody, Fkbp1b antibody

Background:

Background: Has the potential to contribute to the immunosuppressive and toxic effects of FK506 and rapamycin. PPIases accelerate the folding of proteins. It catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides.

Aliases: Peptidyl-prolyl cis-trans isomerase FKBP1B (PPIase FKBP1B) (EC 5.2.1.8) (12.6 kDa FK506-binding protein) (12.6 kDa FKBP) (FKBP-12.6) (FK506-binding protein 1B) (FKBP-1B) (Immunophilin FKBP12.6) (Rotamase) (h-FKBP-12), FKBP1B, FKBP12.6 FKBP1L FKBP9 OTK4

UniProt: P68106

Pathways: Hormone Transport, Negative Regulation of Hormone Secretion, Negative Regulation of Transporter Activity